ABVC BioPharma, Inc (ABVC): מכפיל P/S עתידי

ABVC BioPharma adheres to ESG principles by optimizing resources and utilizing recycled packaging in botanical medicine. This forward price-to-sales chart visualizes market expectation trends, where the 43.70 metric indicates the status of current capitalization. Business success relies on the licensing of ADHD and depression treatments via royalties. The company is currently preparing the results of Phase II trials for its innovative developments.
פילוחי מדדים מקיפים ואנליטיקה עבור ABVC BioPharma, Inc (ABVC)

The forward P/S reflects the ratio of market capitalization to expected revenue, allowing for an assessment of the premium paid for potential sales growth. By analyzing the forward P/S metric, an investor can identify the risk of overvaluation for ABVC BioPharma, given the dependence of revenues on volatile licensing deals and the company's limited working capital liquidity.